BAP1-Related CeRNA (NEAT1/miR-10a-5p/SERPINE1) Promotes Proliferation and Migration of Kidney Cancer Cells

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Apr 15

PMID 35425712

Authors

Rui-Ji Liu

Zhi-Peng Xu

Shu-Ying Li

Jun-Jie Yu

Ning-Han Feng

Bin Xu

Ming Chen

Affiliations

Soon will be listed here.

Abstract

Background: is an important tumor suppressor involved in various biological processes and is commonly lost or inactivated in clear-cell renal cell carcinoma (ccRCC). However, the role of the BAP1-deficient tumor competing endogenous RNA (ceRNA) network involved in ccRCC remains unclear. Thus, this study aims to investigate the prognostic BAP1-related ceRNA in ccRCC.

Methods: Raw data was obtained from the TCGA and the differentially expressed genes were screened to establish a BAP1-related ceRNA network. Subsequently, the role of the ceRNA axis was validated using phenotypic experiments. Dual-luciferase reporter assays and fluorescence hybridization (FISH) assays were used to confirm the ceRNA network.

Results: Nuclear enriched abundant transcript 1 (NEAT1) expression was significantly increased in kidney cancer cell lines. NEAT1 knockdown significantly inhibited cell proliferation and migration, which could be reversed by miR-10a-5p inhibitor. Dual-luciferase reporter assay confirmed miR-10a-5p as a common target of NEAT1 and Serine protease inhibitor family E member 1 (SERPINE1). FISH assays revealed the co-localization of NEAT1 and miR-10a-5p in the cytoplasm. Additionally, the methylation level of SERPINE1 in ccRCC was significantly lower than that in normal tissues. Furthermore, SERPINE1 expression was positively correlated with multiple immune cell infiltration levels.

Conclusions: In BAP1-deficient ccRCC, NEAT1 competitively binds to miR-10a-5p, indirectly upregulating SERPINE1 expression to promote kidney cancer cell proliferation. Furthermore, NEAT1/miR-10a-5p/SERPINE1 were found to be independent prognostic factors of ccRCC.

Citing Articles

DisGeNet: a disease-centric interaction database among diseases and various associated genes.

Hu Y, Guo X, Yun Y, Lu L, Huang X, Jia S Database (Oxford). 2025; 2025.

PMID: 39797570 PMC: 11724190. DOI: 10.1093/database/baae122.

Potential role of P4HB in the tumor microenvironment and its clinical prognostic value: a comprehensive pan-cancer analysis and experimental validation with a focus on KIRC.

Zhang L, Li Y, Xie T, Sun K, Huang X, Xiong W Cancer Cell Int. 2025; 25(1):1.

PMID: 39754183 PMC: 11697512. DOI: 10.1186/s12935-024-03575-z.

Comprehensive analysis of the relationship between RNA modification writers and immune microenvironment in head and neck squamous cell carcinoma.

Li W, Chen Y, Zhang Y, Wen W, Lu Y BMC Immunol. 2024; 25(1):76.

PMID: 39533178 PMC: 11558979. DOI: 10.1186/s12865-024-00667-3.

Multi-omics analysis of Prolyl 3-hydroxylase 1 as a prognostic biomarker for immune infiltration in ccRCC.

Ding G, Wang T, Sun F, Liu M, Tang G, Yu S NPJ Precis Oncol. 2024; 8(1):256.

PMID: 39516330 PMC: 11549470. DOI: 10.1038/s41698-024-00748-x.

Identification of exosomal ceRNA networks as prognostic markers in clear cell renal cell carcinoma.

Zhu T, Fu H, Wang Z, Guo S, Zhang S Medicine (Baltimore). 2024; 103(43):e40167.

PMID: 39470474 PMC: 11521039. DOI: 10.1097/MD.0000000000040167.

References

LaFave L, Beguelin W, Koche R, Teater M, Spitzer B, Chramiec A . Loss of BAP1 function leads to EZH2-dependent transformation. Nat Med. 2015; 21(11):1344-9. PMC: 4636469. DOI: 10.1038/nm.3947. View

van den Berg A, Dijkhuizen T, Draaijers T, Hulsbeek M, Maher E, van den Berg E . Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development. Genes Chromosomes Cancer. 1997; 19(4):228-32. DOI: 10.1002/(sici)1098-2264(199708)19:4<228::aid-gcc4>3.0.co;2-z. View

Cazalla D, Yario T, Steitz J, Steitz J . Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science. 2010; 328(5985):1563-6. PMC: 3075239. DOI: 10.1126/science.1187197. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Louie B, Kurzrock R . BAP1: Not just a BRCA1-associated protein. Cancer Treat Rev. 2020; 90:102091. PMC: 7655689. DOI: 10.1016/j.ctrv.2020.102091. View

Yu H, Xu A, Wu B, Wang M, Chen Z . Long noncoding RNA NEAT1 promotes progression of glioma as a ceRNA by sponging miR-185-5p to stimulate DNMT1/mTOR signaling. J Cell Physiol. 2020; 236(1):121-130. DOI: 10.1002/jcp.29644. View

Boros F, Vecsei L, Klivenyi P . NEAT1 on the Field of Parkinson's Disease: Offense, Defense, or a Player on the Bench?. J Parkinsons Dis. 2020; 11(1):123-138. PMC: 7990444. DOI: 10.3233/JPD-202374. View

Koch A, Jeschke J, Van Criekinge W, van Engeland M, De Meyer T . MEXPRESS update 2019. Nucleic Acids Res. 2019; 47(W1):W561-W565. PMC: 6602516. DOI: 10.1093/nar/gkz445. View

Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi A, Tanaseichuk O . Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019; 10(1):1523. PMC: 6447622. DOI: 10.1038/s41467-019-09234-6. View

10.

Tate J, Bamford S, Jubb H, Sondka Z, Beare D, Bindal N . COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2018; 47(D1):D941-D947. PMC: 6323903. DOI: 10.1093/nar/gky1015. View

11.

Boccaccio C, Comoglio P . A functional role for hemostasis in early cancer development. Cancer Res. 2005; 65(19):8579-82. DOI: 10.1158/0008-5472.CAN-05-2277. View

12.

Kai K, Moriyama M, Haque A, Hattori T, Chinju A, Hu C . Oral Squamous Cell Carcinoma Contributes to Differentiation of Monocyte-Derived Tumor-Associated Macrophages via PAI-1 and IL-8 Production. Int J Mol Sci. 2021; 22(17). PMC: 8430735. DOI: 10.3390/ijms22179475. View

13.

Chin C, Chen S, Wu H, Ho C, Ko M, Lin C . cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014; 8 Suppl 4:S11. PMC: 4290687. DOI: 10.1186/1752-0509-8-S4-S11. View

14.

Landreville S, Agapova O, Matatall K, Kneass Z, Onken M, Lee R . Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin Cancer Res. 2011; 18(2):408-16. PMC: 3261307. DOI: 10.1158/1078-0432.CCR-11-0946. View

15.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

16.

Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View

17.

Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C . Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313(5795):1960-4. DOI: 10.1126/science.1129139. View

18.

Carbone M, Yang H, Pass H, Krausz T, Testa J, Gaudino G . BAP1 and cancer. Nat Rev Cancer. 2013; 13(3):153-9. PMC: 3792854. DOI: 10.1038/nrc3459. View

19.

Poliseno L, Salmena L, Zhang J, Carver B, Haveman W, Pandolfi P . A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010; 465(7301):1033-8. PMC: 3206313. DOI: 10.1038/nature09144. View

20.

Sacco J, Kenyani J, Butt Z, Carter R, Chew H, Cheeseman L . Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors. Oncotarget. 2015; 6(15):13757-71. PMC: 4537048. DOI: 10.18632/oncotarget.3765. View